电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant CD79B (Polatuzumab Biosimilar) 抗体

This anti-CD79B (Polatuzumab Biosimilar) antibody is a Humanized 单克隆 antibody detecting CD79B (Polatuzumab Biosimilar) in FACS 和 in vivo. Suitable for 人.
产品编号 ABIN7795113
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant CD79B (Polatuzumab Biosimilar) 抗体 (ABIN7795113)

抗原

CD79B (Polatuzumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 3
  • 1
  • 1
Humanized

克隆类型

  • 4
  • 1
单克隆

标记

  • 4
  • 1
This CD79B (Polatuzumab Biosimilar) antibody is un-conjugated

应用范围

  • 3
  • 3
  • 1
  • 1
  • 1
Flow Cytometry (FACS), In vivo Studies (in vivo)

质量等级

Research Grade
  • Expression System

    Mammalian cells

    原理

    Polatuzumab Biosimilar, Human CD79B Monoclonal Antibody

    产品特性

    What is polatuzumab biosimilar research grade? Polatuzumab is a humanized IgG1-kappa monoclonal antibody against the human CD79B protein, which is ubiquitously expressed on the surface of malignant B cells. Polatuzumab vedotin is used to treat diffuse large B-cell lymphoma (DLBCL) after at least two other cancer treatments did not work or have stopped working. It is given in combination with bendamustine (Bendeka, Treanda) and a medicine that contains rituximab (Rituxan). Polatuzumab vedotin works by attaching to CD79b and releasing a toxic substance that kills the cancer cells. Polatuzumab biosimilar uses the same protein sequences as the therapeutic antibody polatuzumab.

    纯化方法

    Protein A or G affinity column

    纯度

    >95 % by reducing SDS-PAGE

    内毒素水平

    < 1 EU per 1 mg of the protein by the LAL method

    免疫原

    Human CD79B
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    > 3 mg/mL

    储存条件

    4 °C,-20 °C

    储存方法

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • 抗原

    CD79B (Polatuzumab Biosimilar)

    别名

    Polatuzumab Biosimilar

    物质类

    Biosimilar
You are here: